ORIGINAL RESEARCH article

Front. Radiol.

Sec. Neuroradiology

Volume 5 - 2025 | doi: 10.3389/fradi.2025.1616293

Brain tumor segmentation using deep learning: high performance with minimized MRI data

Provisionally accepted
Jacky  HuangJacky HuangBanu  YagmurluBanu YagmurluPowell  MolettiPowell MolettiRichard  LeeRichard LeeAbigail  VonderploegAbigail VonderploegHumaira  NoorHumaira NoorRohan  BarejaRohan BarejaYiheng  LiYiheng LiMichael  IvMichael IvHaruka  ItakuraHaruka Itakura*
  • School of Medicine, Stanford University, Stanford, United States

The final, formatted version of the article will be published soon.

Brain tumor segmentation with MRI is a challenging task, traditionally relying on manual delineation of regions-of-interest across multiple imaging sequences. However, this data-intensive approach is time-consuming. We aimed to optimize the process by using a deep learning (DL) based model while minimizing the number of MRI sequences required to segment gliomas.We trained a 3D U-Net DL model using the annotated 2018 MICCAI BraTS dataset (training dataset, n=285), focusing on sub-segmenting enhancing tumor (ET) and tumor core (TC). We compared the performances of models trained on four different combinations of MRI sequences: T1C-only, FLAIR-only, T1C+FLAIR and T1+T2+T1C+FLAIR to evaluate whether a smaller MRI data subset could achieve comparable performance. We evaluated the performance on four different sequence combinations using 5-fold cross-validation on the training dataset and our test dataset (n=358) consisting of samples from a separately held-out 2018 BraTS validation set (n=66) and 2021 BraTS datasets (n=292). Dice scores on both datasets were assessed to measure model performance.Dice scores on cross-validation showed that T1C+FLAIR (ET: 0.814, TC: 0.856) matched or outperformed those of T1+T2+T1C+FLAIR (ET: 0.785, TC: 0.841), T1C-only (ET: 0.781, TC: 0.852) and FLAIR-only (ET: 0.008, TC: 0.619). Results on the test dataset also showed that T1C+FLAIR (ET: 0.867, TC: 0.926) matched or outperformed those of T1+T2+T1C+FLAIR (ET: 0.835, TC: 0.908), T1C-only (ET: 0.726, TC: 0.928), and FLAIR-only (ET: 0.056, TC: 0.543). T1C+FLAIR excelled in both ET and TC, exceeding the performance of the four-sequence dataset. T1C-only matched T1C+FLAIR in TC performance. Similarly, T1C and T1C+FLAIR also outperformed in ET delineation by sensitivity (0.829) and Hausdorff distance (5.964) on the test set. Across all configurations, specificity remained high (≥0.958). T1C performed well in TC delineation (sensitivity: 0.737), but the inclusion of all sequences led to improvement (0.754). Hausdorff distances clustered in a narrow range (17.622 -33.812) for TC delineation across the configurations.DL-based brain tumor segmentation can achieve high accuracy using only two MRI sequences (T1C+FLAIR). Reduction of multiple sequence dependency may enhance DL generalizability and dissemination in both clinical and research contexts. Our findings may ultimately help mitigate human labor intensity of a complex task integral to medical imaging analysis.

Keywords: deep learning, Brain tumor segmentation, MRI, Glioma, CNNs (Convolutional Neural Networks)

Received: 22 Apr 2025; Accepted: 10 Jun 2025.

Copyright: © 2025 Huang, Yagmurlu, Moletti, Lee, Vonderploeg, Noor, Bareja, Li, Iv and Itakura. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Haruka Itakura, School of Medicine, Stanford University, Stanford, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.